Risk of Symptomatic Intracerebral Hemorrhage in Patients Treated with Intra-Arterial Thrombolysis

Oliver C. Singer,Joachim Berkefeld,Matthias W. Lorenz,Jens Fiehler,Gregory W. Albers,Maarten G. Lansberg,Andreas Kastrup,Alex Rovira,David S. Liebeskind,Achim Gass,Charlotte Rosso,Laurent Derex,Jong S. Kim,Tobias Neumann-Haefelin

Risk of Symptomatic Intracerebral Hemorrhage in Patients Treated with Intra-Arterial Thrombolysis

2009

Oliver C. Singer
Joachim Berkefeld
Matthias W. Lorenz
Jens Fiehler
Gregory W. Albers
Maarten G. Lansberg
Andreas Kastrup
Alex Rovira
David S. Liebeskind
Achim Gass
Charlotte Rosso
Laurent Derex
Jong S. Kim
Tobias Neumann-Haefelin

Background: In intra-arterial (IA) thrombolysis trials, higher rates of symptomatic intracerebral haemorrhage (sICH) were found than in trials with intravenous (IV) recombinant tiss

Keywords:

Thrombolysis
Intracerebral hemorrhage
Fibrinolytic agent
Tissue plasminogen activator
Diabetes mellitus
Stroke
Recombinant tissue plasminogen activator
Retrospective cohort study
Medicine
Surgery
Anesthesia
in patient

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations